Fortress Biotech's low P/S ratio may be due to anticipated p...

Fortress Biotech's low P/S ratio may be due to anticipated poor growth or falling revenue. Its forecast growth being lower than the industry average could be causing its P/S to lag behind peers. This suggests the share price may not rise significantly soon.